Comparison 4. Griseofulvin versus azole.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Clinical cure	5	222	Risk Ratio (M‐H, Random, 95% CI)	0.94 [0.45, 1.96]
1.1 Short‐term follow‐up (≤ 52 weeks)	2	60	Risk Ratio (M‐H, Random, 95% CI)	0.89 [0.32, 2.45]
1.2 Long‐term follow‐up (> 52 weeks)	3	162	Risk Ratio (M‐H, Random, 95% CI)	1.00 [0.34, 2.93]
2 Mycological cure	5	222	Risk Ratio (M‐H, Random, 95% CI)	0.87 [0.50, 1.51]
2.1 Short‐term follow‐up (≤ 52 weeks)	2	60	Risk Ratio (M‐H, Random, 95% CI)	0.96 [0.52, 1.76]
2.2 Long‐term follow‐up (> 52 weeks)	3	162	Risk Ratio (M‐H, Random, 95% CI)	0.58 [0.16, 2.10]
3 Adverse events	2	143	Risk Ratio (M‐H, Random, 95% CI)	2.41 [1.56, 3.73]
4 Recurrence rate	1	7	Risk Ratio (M‐H, Random, 95% CI)	4.0 [0.26, 61.76]